CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C13604 | BRD-K35369722 | BRD-K35369722 | -- | -- | -- | Details |
| C13605 | BRD-K35371149 | BRD-K35371149 | -- | -- | -- | Details |
| C13606 | BRD-K35376105 | BRD-K35376105 | -- | -- | -- | Details |
| C13607 | BRD-K35377380 | I-OMe-AG-538 | -- | -- | -- | Details |
| C13608 | BRD-K35380368 | BRD-K35380368 | -- | -- | -- | Details |
| C13609 | BRD-K35383890 | BRD-K35383890 | -- | -- | -- | Details |
| C13610 | BRD-K35386584 | BRD-K35386584 | -- | -- | -- | Details |
| C13611 | BRD-K35389996 | BRD-K35389996 | -- | -- | -- | Details |
| C13612 | BRD-K35400569 | BRD-K35400569 | -- | -- | -- | Details |
| C13613 | BRD-K35404627 | BRD-K35404627 | -- | -- | -- | Details |
| C13614 | BRD-K35404971 | BRD-K35404971 | -- | -- | -- | Details |
| C13615 | BRD-K35407043 | BRD-K35407043 | -- | -- | -- | Details |
| C13616 | BRD-K35410462 | BRD-K35410462 | -- | -- | -- | Details |
| C13617 | BRD-K35413741 | BRD-K35413741 | -- | -- | -- | Details |
| C13618 | BRD-K35413818 | BRD-K35413818 | -- | -- | -- | Details |
| C13619 | BRD-K35414268 | BRD-K35414268 | -- | -- | -- | Details |
| C13620 | BRD-K35418438 | BRD-K35418438 | -- | -- | -- | Details |
| C13621 | BRD-K35421408 | BRD-K35421408 | -- | -- | -- | Details |
| C13622 | BRD-K35422614 | BRD-K35422614 | -- | -- | -- | Details |
| C13623 | BRD-K35424448 | dimethyl-terephthalate | -- | -- | -- | Details |
| C13624 | BRD-K35424586 | SA-247714 | -- | -- | -- | Details |
| C13625 | BRD-K35429092 | BRD-K35429092 | -- | -- | -- | Details |
| C13626 | BRD-K35429158 | BRD-K35429158 | -- | -- | -- | Details |
| C13627 | BRD-K35429561 | BRD-K35429561 | -- | -- | -- | Details |
| C13628 | BRD-K35430135 | SR-59230A | ADRB3 | Adrenergic receptor antagonist | -- | Details |
| C13629 | BRD-K35432283 | BRD-K35432283 | -- | -- | -- | Details |
| C13630 | BRD-K35440818 | BRD-K35440818 | -- | -- | -- | Details |
| C13631 | BRD-K35440877 | BRD-K35440877 | -- | -- | -- | Details |
| C13632 | BRD-K35441510 | BRD-K35441510 | -- | -- | -- | Details |
| C13633 | BRD-K35442564 | BRD-K35442564 | -- | -- | -- | Details |
| C13634 | BRD-K35443780 | BRD-K35443780 | -- | -- | -- | Details |
| C13635 | BRD-K35451051 | BRD-K35451051 | -- | -- | -- | Details |
| C13636 | BRD-K35451338 | BRD-K35451338 | -- | -- | -- | Details |
| C13637 | BRD-K35455895 | BRD-K35455895 | -- | -- | -- | Details |
| C13638 | BRD-K35458079 | edaravone | -- | -- | -- | Details |
| C13639 | BRD-K35462157 | BRD-K35462157 | -- | -- | -- | Details |
| C13640 | BRD-K35462725 | BRD-K35462725 | -- | -- | -- | Details |
| C13641 | BRD-K35462787 | BRD-K35462787 | -- | -- | -- | Details |
| C13642 | BRD-K35463509 | geranyl-acetate | -- | -- | -- | Details |
| C13643 | BRD-K35468072 | BRD-K35468072 | -- | -- | -- | Details |
| C13644 | BRD-K35468722 | SA-1973507 | -- | -- | -- | Details |
| C13645 | BRD-K35469110 | BRD-K35469110 | -- | -- | -- | Details |
| C13646 | BRD-K35470597 | BRD-K35470597 | -- | -- | -- | Details |
| C13647 | BRD-K35472285 | BRD-K35472285 | -- | -- | -- | Details |
| C13648 | BRD-K35480932 | BRD-K35480932 | -- | -- | -- | Details |
| C13649 | BRD-K35483542 | alitretinoin | RARA; RARB; RARG; RXRA; RXRB; RXRG | Retinoid receptor agonist | -- | Details |
| C13650 | BRD-K35491869 | BRD-K35491869 | -- | -- | -- | Details |
| C13651 | BRD-K35493431 | BRD-K35493431 | -- | -- | -- | Details |
| C13652 | BRD-K35498378 | alrestatin | AKR1B1 | Aldose reductase inhibitor | -- | Details |
| C13653 | BRD-K35498412 | FQI-2 | -- | -- | -- | Details |
| C13654 | BRD-K35510956 | BRD-K35510956 | -- | -- | -- | Details |
| C13655 | BRD-K35514965 | BRD-K35514965 | -- | -- | -- | Details |
| C13656 | BRD-K35517098 | BRD-K35517098 | -- | -- | -- | Details |
| C13657 | BRD-K35520305 | dacarbazine | -- | -- | -- | Details |
| C13658 | BRD-K35520972 | BRD-K35520972 | -- | -- | -- | Details |
| C13659 | BRD-K35522276 | BRD-K35522276 | -- | -- | -- | Details |
| C13660 | BRD-K35522326 | BRD-K35522326 | -- | -- | -- | Details |
| C13661 | BRD-K35527855 | BRD-K35527855 | -- | -- | -- | Details |
| C13662 | BRD-K35531059 | molsidomine | GUCY1A1 | Guanylyl cyclase activator | -- | Details |
| C13663 | BRD-K35535652 | BRD-K35535652 | -- | -- | -- | Details |
| C13664 | BRD-K35544244 | BRD-K35544244 | -- | -- | -- | Details |
| C13665 | BRD-K35553576 | n-bromoacetyltryptamine | -- | -- | -- | Details |
| C13666 | BRD-K35554380 | BRD-K35554380 | -- | -- | -- | Details |
| C13667 | BRD-K35558120 | BRD-K35558120 | -- | -- | -- | Details |
| C13668 | BRD-K35558836 | BRD-K35558836 | -- | -- | -- | Details |
| C13669 | BRD-K35559145 | levomepromazine | DRD2; DRD3; DRD4 | Dopamine receptor antagonist | -- | Details |
| C13670 | BRD-K35560933 | BRD-K35560933 | -- | -- | -- | Details |
| C13671 | BRD-K35562235 | BRD-K35562235 | -- | -- | -- | Details |
| C13672 | BRD-K35568648 | BRD-K35568648 | -- | -- | -- | Details |
| C13673 | BRD-K35571012 | BRD-K35571012 | -- | -- | -- | Details |
| C13674 | BRD-K35573744 | erbstatin-analog | EGFR | EGFR inhibitor; Tyrosine kinase inhibitor | -- | Details |
| C13675 | BRD-K35577141 | BRD-K35577141 | -- | -- | -- | Details |
| C13676 | BRD-K35584941 | BRD-K35584941 | -- | -- | -- | Details |
| C13677 | BRD-K35586044 | yohimbine | ADRA2A; ADRA2B; ADRA2C; HTR1A; HTR1B; HTR1D; HTR2B | Adrenergic receptor antagonist | -- | Details |
| C13678 | BRD-K35587518 | BRD-K35587518 | -- | -- | -- | Details |
| C13679 | BRD-K35588268 | BRD-K35588268 | -- | -- | -- | Details |
| C13680 | BRD-K35589454 | danegaptide | -- | -- | -- | Details |
| C13681 | BRD-K35589880 | BRD-K35589880 | -- | -- | -- | Details |
| C13682 | BRD-K35596700 | BRD-K35596700 | -- | -- | -- | Details |
| C13683 | BRD-K35601925 | CS-917 | FBP1 | Fructose biphosphate inhibitor | -- | Details |
| C13684 | BRD-K35604418 | MIM-1 | -- | -- | -- | Details |
| C13685 | BRD-K35613686 | BRD-K35613686 | -- | -- | -- | Details |
| C13686 | BRD-K35614154 | BRD-K35614154 | -- | -- | -- | Details |
| C13687 | BRD-K35615823 | BRD-K35615823 | -- | -- | -- | Details |
| C13688 | BRD-K35616093 | BRD-K35616093 | -- | -- | -- | Details |
| C13689 | BRD-K35616138 | BRD-K35616138 | -- | -- | -- | Details |
| C13690 | BRD-K35617935 | BRD-K35617935 | -- | -- | -- | Details |
| C13691 | BRD-K35625946 | BRD-K35625946 | -- | -- | -- | Details |
| C13692 | BRD-K35628245 | BRD-K35628245 | -- | -- | -- | Details |
| C13693 | BRD-K35629949 | SR-27897 | CCKAR | CCK receptor antagonist | -- | Details |
| C13694 | BRD-K35635390 | BRD-K35635390 | -- | -- | -- | Details |
| C13695 | BRD-K35635568 | BRD-K35635568 | -- | -- | -- | Details |
| C13696 | BRD-K35637774 | BRD-K35637774 | -- | -- | -- | Details |
| C13697 | BRD-K35638681 | BRD-K35638681 | -- | -- | -- | Details |
| C13698 | BRD-K35639494 | BRD-K35639494 | -- | -- | -- | Details |
| C13699 | BRD-K35646839 | BRD-K35646839 | -- | -- | -- | Details |
| C13700 | BRD-K35654724 | BRD-K35654724 | -- | -- | -- | Details |
| C13701 | BRD-K35660899 | BRD-K35660899 | -- | -- | -- | Details |
| C13702 | BRD-K35667841 | BRD-K35667841 | -- | -- | -- | Details |
| C13703 | BRD-K35668999 | BRD-K35668999 | -- | -- | -- | Details |